In this younger patient population, diazepam nasal spray was readily absorbed and demonstrated a consistent PK profile with that of older children and adults aged 6 to 59 years.

The nasal spray had to go through many rounds of clinical testing, with some shown to improve depression, while others showed no improvement over a placebo. In 2019, the FDA approved Spravato for ...

Major depressive disorder (MDD) affects approximately 280 million people globally and is one of the leading causes of ...

The US Food and Drug Administration (FDA) has approved Neurelis’ diazepam nasal spray, Valtoco, for the short-term treatment ...

Here's the lowdown from allergy doctors on how to get relief, from which medicines to use — and how to best use them — to ...

The company is developing psychedelics for depression, and hopes to go public within a year of its next published results, per documents seen by BI.

Nasal Spray 8 mg, by Health Canada for the treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression, for adult patients. KLOXXADO ...

A nasal spray, referred to as nasal anti-CD3 ... “It goes beyond their discharge, with all the spectrum of PTSD, anxiety, depression, and cognitive decline.” Following successful trials ...